A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

Stephen A. Harrison, Pierre Bédossa, Cynthia D. Guy, +26

New England Journal of Medicine

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba, +380

The Lancet

Interim AnalysisMetabolic Associated SteatohepatitisHepatologyPlacebo-controlled Phase 3Nonalcoholic Fatty Liver Disease +5

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue, +632

Journal of Hepatology

FibrosisHepatologyLiver PhysiologyClinical TrialsPathology +7

A Polymorphism Near IL28B Is Associated With Spontaneous Clearance of Acute Hepatitis C Virus and Jaundice

Hans L. Tillmann, A. Thompson, Keyur Patel, +19

Gastroenterology

Il28b Is AssociatedAutoimmune DiseaseHepatitis CHepatologyViral Hepatitis +10

Use of Intestinal Ultrasound to Monitor Crohn’s Disease Activity

Torsten Kucharzik, Bianca M. Wittig, Ulf Helwig, +50

Clinical Gastroenterology and Hepatology

Medical UltrasoundIntestinal UltrasoundGastroenterologyDiagnosisUltrasound +2

Decrease of CA 19–9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer

U. Halm, Thomas L. Schumann, Ingolf Schiefke, +3

British Journal of Cancer

Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma

Marcus Wiedmann, Karel Caca, Frieder Berr, +6

Cancer

Non-Invasive Assessment of Hepatic Steatosis in Patients with NAFLD Using Controlled Attenuation Parameter and 1H-MR Spectroscopy

Thomas Karlas, David Petroff, Nikita Garnov, +14

PLoS ONE

Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection

Ingolf Schiefke

World Journal of Gastroenterology

Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension

Guadalupe García–Tsao, Jaime Bosch, Zeid Kayali, +71

Journal of Hepatology

Severe Portal HypertensionHepatologyLiver PhysiologyGastroenterologyPlacebo-controlled Trial +6